Whitepaper: Enabling data integrity during drug manufacturing
Posted: 25 June 2020 | Thermo Fisher Scientific | No comments yet
High data quality and integrity is critical to ensure successful manufacturing of a drug. This whitepaper discusses how utilisation of software systems such as SampleManager LIMS enables and promotes compliance with regulations for the manufacturing of a drug.
Promoting an environment to ensure high quality data
When discussing the success of a drug therapy, a common topic amongst biopharmaceutical companies is data quality and data integrity; what the challenges are and what the key elements are to ensure the latest discovery is patentable, does not result in re-conducting critical research or development studies, is accepted by the regulators or does not result in a recall of a batch of product. A common challenge expressed amongst the industry is how to implement processes that promote and ensure regulatory guidance is being followed and that their data is of the highest integrity. High data quality and integrity is critical to ensure successful manufacturing of a drug.
Related content from this organisation
- ebook: Twin-screw extrusion for pharmaceutical applications
- Biopharmaceuticals contributing to manufacturing outsourcing trend
- Biologics driving continuous bioprocessing market expansion
- Mycoplasma testing market expected to value nearly $2 million by 2031
- Drug development trends: insight from Thermo Fisher’s Anil Kane
Issue
Related topics
Data integrity, Drug Manufacturing, Regulation & Legislation